Cell therapy
Programmes that take cells — usually from a patient's own follicles — multiply them outside the body, and return them to the scalp in the hope of restoring or creating follicles.
No cell therapy for hair loss holds a marketing authorisation from any medicines regulator, and "hair cloning" has been reported as imminent for twenty years. The closest thing that exists: since 2024, Japan permits one autologous cell therapy at specific licensed clinics under its regenerative-medicine framework — a sanctioned procedure, not an approved product. The honest version is below: which programmes exist, what stage each has actually reached, and which have already stopped.
Available today
Nothing taking this approach is approved, anywhere.
In development
- Epibiotech dermal papilla cell therapyPhase 1/2EpibiotechMedium
- HairClone follicle banking & cell therapyPhase 1HairCloneMedium
Discontinued
Kept deliberately — the history of failures is as informative as the successes.
- RCH-01Phase 2RepliCel Life SciencesMedium
- Stemson Therapeutics hair follicle neogenesisDiscontinuedStemson TherapeuticsMedium
This page is generated from the register and updates with it. It does not rank treatments by efficacy or announce launch dates — see how we track. A research register, not medical advice: talk to a dermatologist about your own case.